Antibiotic resistant β-lactamases are diverse and complex enzymes produced by most of the Gram-negative bacteria that are mediated by number of plasmids. The impact of these enzymes has posed a major threat to the health sectors and has challenged the available treatment options for both community and hospital acquired infections. These include the uncomplicated most severe life-threatening infections. Moreover, with resistance to the cephalosporin drugs these Multidrug Resistance strains exhibit co-resistance patterns with different class of antibiotics which is a cause of concern that leads to narrow the limited treatment options. It is alarming situation since there is a steep rise in MDR-Beta lactamase pathogens mainly in Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa. Currently, the clinical detection of Extended Spectrum of β-Lactamases (ESβL) and MβL producing pathogens are carried out by antibiotic sensitivity test on the guidelines of Clinical and Laboratory Standards Institute (formerly the National Committee for Clinical Laboratory Standards) since, the other methods being too expensive. The choice of antimicrobial treatment for infections should rely on the clinical data and the tests (AST) in asymptomatic and mild cases. However, this does not imply for critical infections. The last resorts of treatment for ESβL pathogens are carbapenem and nevertheless, resistances have also been reported for the same. With increasing resistance rate to the antibiotics, it is very essential to follow the guidelines for detection, implementation of antibiotic rotation to reduce these pathogens, followed by the efficient infection control practices and strategies to avoid such outbreaks.
Pyogenic infections are caused by various pathogens leading to pus formation and that can be attributed due to a wound either through accident or during surgery leading to infection spread. There are pathogenic strains that are not uncommon in hospital settings like Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter etc., that are multidrug resistant (MDR) and are a cause of concern. The bacteriological profile in the pyogenic infections tends to be same but there is a vast difference with the antibiotic resistant patterns in different hospital settings. Hence, the aim was to study the antibiotic susceptibility profiles and Extended spectrum βeta Lactamases (ESβL) production in these pathogens. A prospective study was carried out in Silchar Medical College and Hospital Assam, India, over a four-month period from February to May 2021. The samples were processed using Blood and MacConkey's agar. Further, these isolated pathogens were identified by standard morphological, cultural and biochemical tests. The antibiotic susceptibility test was conducted by Kirby Bauer disc diffusion method and ESβL production was detected by using combined disk diffusion test. It was observed that the identified pathogens had an incidence rate of 84.2% and further revealed that Gram negative had a higher incidence rate compared to Gram positive with 59.8%. The pathogens isolated from pus samples had a maximum of Klebsiella sps (19.64%) and the lowest was E. coli with 5.36%. Antibiotic susceptibility test (AST) of Gram-negative bacterial isolates showed the highest incidence with aztreonam (40.6%) and the lowest was observed in Piperacillin/Tazobactam with 7.5%. The only Gram positive
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.